Patient Capital Management, LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001854794
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Samantha McLemore — tracked via quarterly SEC 13F filings · All famous investors
Q2 2025 · 40 positions · Total reported value $2.22B · Top-10 concentration 47.7% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 69.0% · 3 new · 23 cut · 3 exited
Active Share (vs S&P 500): 80.6% · vs QQQ: 81.3% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): +3.9% · vs SPY +1.8% · Prev Value $2.99B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -0.4% · vs SPY -2.6% · Latest Value $2.96B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q2 2025 13F filing, Patient Capital Management, LLC disclosed 40 equity positions with a combined reported value of $2.22B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 47.7% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.
The largest disclosed positions as of Q2 2025 were QXO ($140.92M), AMZN ($123.62M), C ($114.55M). By sector, the heaviest allocations are Consumer Discretionary 34.6%, Financials 19.6%. Versus the prior quarter, allocation shifted toward Technology (+2.7pp), Financials (+2.0pp) and away from Consumer Staples (-0.8pp), Consumer Discretionary (-1.0pp).
Versus the prior quarter, Patient Capital Management, LLC opened 3 new positions, trimmed 23 and fully exited 3, a turnover rate of 69.0% of positions. The portfolio's overlap with the prior quarter was 84% of names.
The largest new positions opened in Q2 2025 were UNH ($59.88M), TEM ($24.69M), NE ($19.07M).
Of the 3 positions fully exited versus the prior quarter, the largest were NFE ($20.63M), CVNA ($9.89M), BRLT ($158.00K).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2025)
Insider Transactions (Form 4)
Latest Samantha McLemore buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Patient Capital Management, LLC is an SEC-registered 13F filer based in Baltimore, MD, United States. As of Q2 2026 it reported 39 US equity positions with a combined value of $2.99B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: BALTIMORE, MD, United States
- SEC registration: 801-118170 (status: Approved), registered 2020-03-05
- Regulatory AUM (Form ADV): $2.50B as of 2026-03-27
- Client mix (by RAUM): registered investment companies 85%, pension and profit-sharing plans 9%
- Manages 1 private funds, of which 1 hedge funds
- Website: patientcapitalmanagement.com
Portfolio Structure
- 39 positions · $2.99B reported value (Q2 2026)
- Top 10 holdings = 52.4% of reported value
- Largest position: RPRX (ROYALTY PHARMA PLC) at 6.8%
- Average position size: $76.65M
Sector Tilt
- Consumer Discretionary 28.4%
- Health Care 19.9%
- Financials 17.9%
- (classified holdings cover 96% of value)
Quarterly Activity
- Q2 2026: 2 new, 10 added, 18 reduced, 2 exited
- 9 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
6.54M | $140.92M | 6.36% | Reduce | |
| 2 |
|
563.48K | $123.62M | 5.58% | Reduce | |
| 3 |
|
1.35M | $114.55M | 5.17% | Reduce | |
| 4 |
|
613.05K | $108.04M | 4.88% | Add | |
| 5 |
|
2.99M | $107.66M | 4.86% | Add | |
| 6 |
|
144.29K | $106.50M | 4.81% | Reduce | |
| 7 |
|
634.17K | $100.19M | 4.52% | Add | |
| 8 |
|
4.71M | $95.49M | 4.31% | Add | |
| 9 |
|
1.24M | $85.67M | 3.87% | Reduce | |
| 10 |
|
4.08M | $73.90M | 3.33% | Reduce | |
| 11 |
|
203.50K | $71.32M | 3.22% | Hold | |
| 12 |
|
1.94M | $65.53M | 2.96% | Reduce | |
| 13 |
|
1.74M | $64.93M | 2.93% | Add | |
| 14 |
|
2.13M | $64.17M | 2.90% | Reduce | |
| 15 |
|
191.93K | $59.88M | 2.70% | New | |
| 16 |
|
1.03M | $58.85M | 2.66% | Reduce | |
| 17 |
|
2.23M | $58.53M | 2.64% | Add | |
| 18 |
|
620.23K | $58.30M | 2.63% | Hold | |
| 19 |
|
3.16M | $57.50M | 2.60% | Reduce | |
| 20 |
|
499.11K | $56.60M | 2.56% | Reduce | |
| 21 |
|
582.19K | $55.55M | 2.51% | Add | |
| 22 |
|
668.65K | $53.24M | 2.40% | Hold | |
| 23 |
|
503.38K | $50.98M | 2.30% | Reduce | |
| 24 |
|
944.75K | $46.49M | 2.10% | Reduce | |
| 25 |
|
899.70K | $44.25M | 2.00% | Add | |
| 26 |
|
261.86K | $44.17M | 1.99% | Reduce | |
| 27 |
|
320.47K | $40.25M | 1.82% | Reduce | |
| 28 |
|
19.34M | $33.26M | 1.50% | Add | |
| 29 |
|
1.46M | $28.88M | 1.30% | Reduce | |
| 30 |
|
789.13K | $25.76M | 1.16% | Hold | |
| 31 |
|
388.63K | $24.69M | 1.11% | New | |
| 32 |
|
16.27M | $23.10M | 1.04% | Reduce | |
| 33 |
|
718.29K | $19.07M | 0.86% | New | |
| 34 |
|
2.69M | $18.67M | 0.84% | Reduce | |
| 35 |
|
808.00K | $12.33M | 0.56% | New | |
| 36 |
|
29.38K | $8.52M | 0.38% | Hold | |
| 37 |
|
735.47K | $8.23M | 0.37% | Reduce | |
| 38 |
|
139.70K | $3.88M | 0.17% | Add | |
| 39 |
|
12.50K | $1.32M | 0.06% | Hold | |
| 40 |
|
50.00K | $914.50K | 0.04% | Hold | |
FAQ
What did Patient Capital Management, LLC buy in 2025-Q2?
In its 2025-Q2 13F filing, Patient Capital Management, LLC reported 40 equity positions worth $2.22B in aggregate; its largest disclosed positions were QXO ($140.92M), AMZN ($123.62M), C ($114.55M).
How large is Patient Capital Management, LLC's portfolio?
Patient Capital Management, LLC reported $2.22B of long equity holdings across 40 positions as of 2025-Q2. Top-10 holdings account for 47.7% of reported value.
What is Patient Capital Management, LLC's investment style?
HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.